Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD [Phase 1, Phase 2]
Clinical trial update for HLX04-O in subjects with age-related macular degeneration across Phase 1 and Phase 2 completed.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA [Phase 2]
Phase 2 trial results update for elamipretide in age-related macular degeneration with non-central geographic atrophy.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 2]
Phase 2 long-term safety and tolerability study of Galegenimab (FHTR2163) in geographic atrophy due to age-related macular degeneration has …
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy [Phase 1]
Phase 1 study evaluating tolerability of different doses of BI 754132 in geographic atrophy due to age-related macular degeneration; trial t…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® [Phase 3]
Phase 3 trial update evaluating efficacy, safety, pharmacokinetics, and immunogenicity of GNR-067 in Age Related Macular Degeneration (ARMD)…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Adjunct Episcleral Brachytherapy for PCV [Phase 3]
Phase 3 clinical trial update for adjunct episcleral brachytherapy in polypoidal choroidal vasculopathy and age-related macular degeneration…
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial comparing intravitreal APL-2 therapy to sham injections in geographic atrophy due to age-related macular degeneration has comp…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial comparing intravitreal APL-2 vs sham injections in geographic atrophy due to age-related macular degeneration has completed wi…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD [Phase 2]
Phase 2 trial evaluating metformin to slow geographic atrophy progression in age-related macular degeneration has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration [Phase 2]
Phase II study assessing RBM-007 alone and with Eylea in wet age-related macular degeneration has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]
Phase 1/2 safety and exploratory efficacy study of SF0166 for neovascular age-related macular degeneration has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for RBM-007 in treatment-naïve exudative age-related macular degeneration has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration [Phase 1, Phase 2]
This clinical trial update reports safety and efficacy results for OpRegen in advanced dry age-related macular degeneration from a Phase 1/2…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration [Phase 3]
Phase 3 trial update on aflibercept for neovascular age-related macular degeneration assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration [Phase 1, Phase 2]
Clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating transpalpebral microcurrent stimulation to improve visual…
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy [Phase 3]
Phase 3 trial investigating BroLucizumab in pachychoroid neovasculopathy and age-related macular degeneration is currently in an unknown sta…
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Alpha MSH in Ocular Disease [NA]
A completed clinical trial investigating Alpha MSH for advanced dry macular degeneration; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration [Phase 3]
Phase 3 trial evaluating aflibercept after ranibizumab in exudative age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects [Phase 2]
Phase 2 clinical study of Sanhuangjingshimingwan in wet age-related macular degeneration completed.
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration [Phase 2]
Phase 2 trial of multiple-dose intravitreal GEM103 for neovascular age-related macular degeneration was terminated, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD [Phase 2, Phase 3]
A trial update on intravitreal conbercept using modified treat-and-extend regimens for exudative age-related macular degeneration is being s…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells [Phase 1, Phase 2]
A clinical trial evaluating retinal stem and progenitor cell therapy for age-related macular degeneration is in Phase 1/Phase 2, with no cur…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration [Phase 1, Phase 2]
A clinical trial update on prophylactic ranibizumab for exudative age-related macular degeneration across phase 1 and phase 2 has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL) [NA]
Clinical trial update related to Age-related Macular Degeneration in the VITAL study; status and results not clearly specified.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD [Phase 2]
Phase 2 trial evaluating the safety and efficacy of ALS-L1023 in combination with ranibizumab for wet age-related macular degeneration has c…